Quince Therapeutics S.p.A.

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Quince Therapeutics S.p.A. sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials none currently recruiting 5 completed later-stage tilt upper quartile by trial count

Quince Therapeutics S.p.A.: 7 sponsored US clinical trials, none currently recruiting.

Quince Therapeutics S.p.A. sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 4 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 2 trials.

Upper-quartile sponsor footprint

Quince Therapeutics S.p.A. sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

7 total, page 1 of 1

TERMINATED Phase 3

Open-Label Extension of EryDex Study IEDAT-04-2022

NCT06664853
COMPLETED Phase 3

Evaluate the Neurological Effects of EryDex on Subjects With A-T

NCT06193200
TERMINATED Phase 3

Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study

NCT03563053
COMPLETED Phase 3

Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients

NCT02770807
COMPLETED Phase 1

Recovery and Survival of EryDex in Non-patient Volunteers

NCT02380924
COMPLETED

International Ataxia Rating Scale in Younger Patients

NCT01942850
COMPLETED Phase 1

EryDex Pharmacokinetics in Healthy Volunteers

NCT01925859

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 3 4

Therapeutic Areas

Healthy 2

How the Quince Therapeutics S.p.A. archive is shaped

7 indexed studies, none listed as recruiting (0% open); 5 completed (71%).

Phase mix: 4 late (III/IV) vs 2 early (I/II) (later-stage heavy).

Top condition: Healthy (2 trials), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Quince Therapeutics S.p.A.: archived-pipeline peers nationwide

Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Quince Therapeutics S.p.A. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Quince Therapeutics S.p.A.3M4Life Research89bioAbbott Diagnostics Division10xBio22nd Century Group23andMe3-C Institute for Social Development
Quince Therapeutics S.p.A. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Quince Therapeutics S.p.A. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Quince Therapeutics S.p.A. page

7 registered trials is a research-attention snapshot, not an endorsement of Quince Therapeutics S.p.A. or any single study.

  • None of Quince Therapeutics S.p.A.'s trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Healthy is the condition Quince Therapeutics S.p.A. studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Quince Therapeutics S.p.A. pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.